Up-regulation of Melanin Synthesis by the Antidepressant Fluoxetine
Experimental Dermatology, 05/17/2012
Liao S et al. – The results suggest that fluoxetine may hold a significant therapeutic potential for treating skin hypopigmentation disorders, and serotonin 1A receptor (SR1A) may serve as a novel target in modulating melanogenesis.



